The safety of drug-eluting stents

Therapeutic Advances in Cardiovascular Disease

Volumn 2, Issue 1, 2008, Pages 43-52

  Saia, Francesco ^a   Marzocchi, Antonio ^a   Branzi, Angelo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Drug Eluting Stent; Mortality; Myocardial Infarction; Review; Thrombosis

Indexed keywords

EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

BIOCOMPATIBILITY; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; EVIDENCE BASED MEDICINE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; LONG TERM CARE; MORTALITY; PATHOPHYSIOLOGY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STENT THROMBOSIS; THROMBOSIS; TREATMENT INDICATION;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; HUMANS; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 68749114438     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944707088158     Document Type: Review

References (38)

1. Airoldi, F., Colombo, A., Morici, N., Latib, A., Cosgrave, J., Buellesfeld, L. et al. (2007) Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment. Circulation 116: 745–754.
2. Brunner-La Rocca, H.P., Kaiser, C., Pfisterer, M. (2007) Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET). Eur Heart J 28: 719–725.
3. Camenzind, E., Steg, P.G., Wijns, W. (2007) Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115: 1440–1455; discussion 1455.
4. Chen, M.S., John, J.M., Chew, D.P., Lee, D.S., Ellis, S.G., Bhatt, D.L. (2006) Bare metal stent restenosis is not a benign clinical entity. Am Heart J 151: 1260–1264.
5. Cutlip, D.E., Windecker, S., Mehran, R., Boam, A., Cohen, D.J., van Es, G.A. et al. (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115: 2344–2351.
6. Daemen, J., Wenaweser, P., Tsuchida, K., Abrecht, L., Vaina, S., Morger, C. et al. (2007) Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 369: 667–678.
7. de Feyter, P.J., Kay, P., Disco, C., Serruys, P.W. (1999) Reference chart derived from post-stent-implantation intravascular ultrasound predictors of 6-month expected restenosis on quantitative coronary angiography. Circulation 100: 1777–1783.
8. Fajadet, J., Wijns, W., Laarman, G.J., Kuck, K.H., Ormiston, J., Munzel, T. et al. (2006) Randomized, double-blind, multicenter study of the, Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 114: 798–806.
9. Farb, A., Burke, A.P., Kolodgie, F.D., Virmani, R. (2003) Pathological mechanisms of fatal late coronary stent thrombosis in humans. Circulation 108: 1701–1706.
10. Fischman, D.L., Leon, M.B., Baim, D.S., Schatz, R.A., Savage, M.P., Penn, I. et al. (1994) A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 331: 496–501.
11. Jensen, L.O., Maeng, M., Kaltoft, A., Thayssen, P., Hansen, H.H., Bottcher, M. et al. (2007) Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions. J Am Coll Cardiol 50: 463–470.
12. Joner, M., Finn, A.V., Farb, A., Mont, E.K., Kolodgie, F.D., Ladich, E. et al. (2006) Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48: 193–202.
13. Kastrati, A., Mehilli, J., Pache, J., Kaiser, C., Valgimigli, M., Kelbaek, H. et al. (2007) Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 356: 1030–1039.
14. Kotani, J., Awata, M., Nanto, S., Uematsu, M., Oshima, F., Minamiguchi, H. et al. (2006) Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 47: 2108–2111.
15. Kuntz, R.E. (2007) Medtronic, Vascular: Endeavor safety analysis. http://www.fda.gov/ohrms/dockets/ac/06/slides/2006-4253oph2_17_Kuntz.pdf (Last accessed november 19th 2007).
16. Lagerqvist, B., James, S.K., Stenestrand, U., Lindback, J., Nilsson, T., Wallentin, L. (2007) Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 356: 1009–1019.
17. Laskey, W.K., Yancy, C.W., Maisel, W.H. (2007) Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7–8, 2006 Circulation 115: 2352–2357.
18. Liistro, F., Fineschi, M., Angioli, P., Sinicropi, G., Falsini, G., Gori, T. et al. (2006) Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry. J Am Coll Cardiol 48: 270–275.
19. Luscher, T.F., Steffel, J., Eberli, F.R., Joner, M., Nakazawa, G., Tanner, F.C. et al. (2007) Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 115: 1051–1058.
20. Marx, S.O. and Marks, A.R. (2001) Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 104: 852–855.
21. Marzocchi, A., Piovaccari, G., Manari, A., Aurier, E., Benassi, A., Saia, F. et al. (2005) Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events. Am J Cardiol 95: 1409–1414.
22. Marzocchi, A., Saia, F., Piovaccari, G., Manari, A., Aurier, E., Benassi, A. et al. (2007) Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation 115: 3181–3188.
23. McFadden, E.P., Stabile, E., Regar, E., Cheneau, E., Ong, A.T., Kinnaird, T. et al. (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364: 1519–1521.
24. Mercado, N., Boersma, E., Wijns, W., Gersh, B.J., Morillo, C.A., de Valk, V., van Es, G.A. (2001) Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 38: 645–652.
25. Moussa, I., Leon, M.B., Baim, D.S., O'Neill, W.W., Popma, J.J., Buchbinder, M. et al. (2004) Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 109: 2273–2278.
26. Nordmann, A.J., Briel, M., Bucher, H.C. (2006) Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J 27: 2784–2814.
27. Pfisterer, M., Brunner-La Rocca, H.P., Buser, P.T., Rickenbacher, P., Hunziker, P., Mueller, C. et al. (2006) Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48: 2584–2591.
28. Serruys, P.W., de Jaegere, P., Kiemeneij, F., Macaya, C., Rutsch, W., Heyndrickx, G. et al. (1994) A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med 331: 489–495.
29. Serruys, P.W., Degertekin, M., Tanabe, K., Abizaid, A., Sousa, J.E., Colombo, A. et al. (2002) Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation 106: 798–803.
30. Serruys, P.W., Kay, I.P., Disco, C., Deshpande, N.V., de Feyter, P.J. (1999) Periprocedural quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the BElgian NEtherlands Stent study (BENESTENT) I., BENESTENT II Pilot, BENESTENT II and MUSIC trials. Multicenter Ultrasound Stent In Coronaries. J Am Coll Cardiol 34: 1067–1074.
31. Sollott, S.J., Cheng, L., Pauly, R.R., Jenkins, G.M., Monticone, R.E., Kuzuya, M., Froehlich, J.P. et al. (1995) Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest 95: 1869–1876.
32. Stettler, C., Wandel, S., Allemann, S., Kastrati, A., Morice, M.C., Schomig, A. et al. (2007) Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 370: 937–948.
33. Stone, G.W., Ellis, S.G., Colombo, A., Dawkins, K.D., Grube, E., Cutlip, D.E. et al. (2007) Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation 115: 2842–2847.
34. Stone, G.W., Ellis, S.G., Cox, D.A., Hermiller, J., O'Shaughnessy, C., Mann, J.T. et al. (2004) A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350: 221–231.
35. Stone, G.W., Moses, J.W., Ellis, S.G., Schofer, J., Dawkins, K.D., Morice, M.C. et al. (2007) Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 356: 998–1008.
36. Tu, J.V., Bowen, J., Chiu, M., Ko, D.T., Austin, P.C., He, Y. et al. (2007) Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357: 1393–1402.
37. Virmani, R., Guagliumi, G., Farb, A., Musumeci, G., Grieco, N., Motta, T. et al. (2004) Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109: 701–705.
38. Wessely, R., Kastrati, A., Schomig, A. (2005) Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent. Ann Intern Med 143: 392–394.